Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Bid to Buy Biosite Clears German Regulators; Offer Expires Friday

NEW YORK (GenomeWeb News) — Biosite said today the German Federal Cartel Office has approved a bid by Beckman Coulter to acquire the company.
 
Beckman's offer, which was approved by the US Federal Trade Commission last week, is set to expire on Friday if it does not close or is not extended.
 
Biosite has been considering a rival offer from Inverness Medical Innovations, which currently owns around 5 percent of Biosite’s stock.
The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.